Researchers find link between topography of the genome and presence of cancer mutations

Researchers at the University of California San Diego have uncovered a connection between the topography of the human genome and the presence of mutations in human cancer.

Innovative testing protocol reduces the lengthy wait for IBD diagnosis

Patients with suspected inflammatory bowel disease (IBD) could benefit from better testing protocols that would reduce the need and lengthy wait for potentially unnecessary colonoscopies,

April 16, 2024

FDA to review Sanofi and Regeneron’s Dupixent sBLA for bullous pemphigoid – Pharmaceutical Technology

Regeneron and Sanofi have collaborated on Dupixent since 2007. Credit: The Washington Post via Getty Images. Sanofi and Regeneron’s blockbuster biologic Dupixent (dupilumab) is poised

February 18, 2025

Novocure fails PhIII in platinum-resistant ovarian cancer

Novocure’s ovarian cancer treatment failed to meet the primary endpoint of overall survival in a Phase III trial, sending the New Jersey biotech’s stock price

August 29, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.